(Q43141598)

14 November 2017

0 references

Marketed therapeutic antibodies compendium (English)

1 reference

14 November 2017

1 reference

1

1 reference

14 November 2017

26 April 2012

1 reference

14 November 2017

Monoclonal Antibodies

1 reference

14 November 2017

4

1 reference

14 November 2017

3

1 reference

14 November 2017

413-415

1 reference

The birth pangs of monoclonal antibody therapeutics: the failure and legacy of Centoxin

14 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

Antibody immunosuppressive therapy in solid-organ transplant: Part I.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

Nimotuzumab, a promising therapeutic monoclonal for treatment of tumors of epithelial origin

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

A better cell line for making hybridomas secreting specific antibodies

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

Which are the antibodies to watch in 2012?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3355480

Delaying approval of a critical drug: safety, efficacy, economics, compassion

15 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22531442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22531442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22531442

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4161/MABS.19931

1 reference

14 November 2017

1 reference

PMC publication ID

3355480

14 November 2017

PubMed publication ID

22531442

1 reference

PMC publication ID

3355480